What is the Market's View on Alpine Immune Sciences Inc (ALPN) Stock's Price and Volume Trends Thursday?

Overall market sentiment has been high on Alpine Immune Sciences Inc (ALPN) stock lately. ALPN receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Alpine Immune Sciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ALPN!

See Full ALPN Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ALPN Stock Today?

Alpine Immune Sciences Inc (ALPN) stock is up 0.1% while the S&P 500 is lower by -0.25% as of 12:22 PM on Thursday, Nov 30. ALPN has risen $0.01 from the previous closing price of $15.47 on volume of 167,062 shares. Over the past year the S&P 500 has gained 14.69% while ALPN has risen 150.65%. ALPN lost -$1.27 per share in the over the last 12 months. To screen for more stocks like Alpine Immune Sciences Inc click here.

More About Alpine Immune Sciences Inc

Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. Click Here to get the full Stock Report for Alpine Immune Sciences Inc stock.